RJT
CNMD icon

Raymond James Trust’s CONMED CNMD Stock Holding History

Raymond James Trust’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,484
Closed -$202K – 1167
2023
Q2 		$202K Buy
+1,484
New +$181K 0.01% 1112
2022
Q2 		– Sell
-1,547
Closed -$230K – 1102
2022
Q1 		$230K Sell
1,547
-32
-2% -$4.47K 0.01% 1025
2021
Q4 		$224K Sell
1,579
-2
-0.1% -$283 0.01% 1047
2021
Q3 		$207K Buy
+1,581
New +$207K 0.01% 1053

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Raymond James Trust's CNMD Position: Q3 2023 in Review

Raymond James Trust sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,484 shares — an estimated $202K sold.

Raymond James Trust first reported a position in CNMD in Q3 2021 and held it in 4 quarters. The position peaked at $230K in Q1 2022. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

  • Raymond James Trust reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
  • Raymond James Trust sold 1,484 CONMED shares in Q3 2023, an estimated $202K.
  • Raymond James Trust first reported a position in CONMED in Q3 2021 and held it in 4 quarters.
  • Raymond James Trust's CONMED position peaked at $230K in Q1 2022.
  • 275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Raymond James Trust's 13F filing for Q3 2023, filed 14 Nov 2023.